NewcelX Ltd. (NCEL)

US · Healthcare · Biotechnology

$3.38-0.29%

Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Net profit

$4.3M

EPS

$-1.05

EPS estimate

$0.00

Market cap

$19.1M

Forward P/E

0.0

P/B

2.63

Book value

$1.51

EPS (TTM)

$-2.16

52-week high

$24.60

52-week low

$1.83

50-day MA

$3.55

200-day MA

$3.11

Beta

0.57

with an average price target of $23.00.

Insiders

68.06%

Institutions

1.35%

Fund	Stake
UBS Group AG	0.01%
Tower Research Capital LLC	0.00%
CoreCap Advisors, LLC	0.00%
Caitong International Asset Management Co., Limited.	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for NewcelX Ltd. — free to start.

Data updated 2026-09-18.